|
GB202102889D0
|
|
Fibre optic chemical sensing
|
|
GB202101700D0
|
|
Antibody detection assay
|
|
GB202019556D0
|
|
Magnetic shield
|
|
GB202019012D0
|
|
Magnetic induction tomography
|
|
WO2021069891A1
|
|
Antiviral compounds and methods
|
|
GB202015427D0
|
|
Magnetoencephalography method and system
|
|
GB202013183D0
|
|
Hemocompatability polymer
|
|
WO2021005584A1
|
|
Non-invasive brain stimulation
|
|
GB202010626D0
|
|
Compound
|
|
WO2020249974A1
|
|
Quantum gravimeters and gradiometers
|
|
GB202007622D0
|
|
Non-invasive brain stimulation
|
|
GB202004068D0
|
|
Antiviral compounds and methods
|
|
GB202001988D0
|
|
Electrical propulsion
|
|
GB202001439D0
|
|
Drug formulations
|
|
GB202000112D0
|
|
Quantum gravimeters and gradiometers
|
|
GB201918438D0
|
|
Magnetic shield
|
|
GB201917607D0
|
|
Magnetic induction tomography
|
|
GB201916506D0
|
|
Corneal tissue
|
|
GB201916446D0
|
|
Compact laser spectroscopy
|
|
WO2020099842A1
|
|
Magnetic optimisation
|
